Table 2.

Percentage of trials (mean ± SEM) with β-bursts during a baseline and stopping period, for all trial types

	No-stop	Non-canceled	Canceled
Baseline	11.6 ± 0.6%	11.7 ± 0.7%	11.2 ± 0.7%
Stopping period	11.8 ± 0.8%	10.5 ± 0.7%	13.1 ± 0.8%